Friday, October 2, 2026 US Financial & Technology Edition
Market Edition
Updated 13:46 EDT
US Money · Insurance · SaaS
America Pulse Independent Financial & Technology News Wire
New York · Markets
Personal Finance · Investing
Banking · SaaS & Technology
Markets LIVE
Equity S&P 500 $764.37 ▲0.23% Equity Nasdaq $742.99 ▲0.44% Equity Dow $508.21 ▼0.07% Equity Gold $382.71 ▲0.49% Equity WTI Oil $149.55 ▲2.67% Equity Bonds 20Y $77.72 ▼0.08% Crypto BTC $86,721.63 ▲3.60% Crypto ETH $2,749.65 ▲2.15% Crypto XRP $1.54 ▲3.74%
Investing Sep 5, 2026

Nuveen Churchill Direct Lending Q2: 27% Discount And 9.5% Expected ROE

Nuveen Churchill Direct Lending maintains a conservative credit profile with a non-accrual ratio of 1.5%. Read more on NCDL stock here.

Nuveen Churchill Direct Lending Reports Second-Quarter Earnings

Nuveen Churchill Direct Lending, a business development company listed on the New York Stock Exchange under the ticker symbol NCDL, recently announced its financial results for the second quarter of 2026. The company's stock is currently trading at a 27% discount, with an expected return on equity of approximately 9.5%.

Financial Highlights

NCDL's total assets stood at nearly $2 billion, with $324 million in liquidity, comprising cash, cash equivalents, and debt capacity. The company's debt-to-equity ratio is around 1.29 times, while its net debt-to-equity ratio is 1.23 times. Net investment income per share remained steady at $0.41, unchanged from the first quarter of 2026.

Investment Portfolio and Credit Quality

At the close of the second quarter, investments measured at fair value represented roughly 97 % of total assets, with 2 % held in cash and cash equivalents. Non‑accrual investments were 1.5 %, well below the sector average of 2.8 % for Q2 2026, indicating a conservative credit‑risk stance that is about twice as favorable as the median for business development companies. The net debt‑to‑equity ratio fell to 1.23 times from 1.26 times at the end of the first quarter.

Portfolio Composition and Leverage

NCDL’s portfolio includes 244 companies. The largest sector exposure is to Healthcare & Pharmaceuticals at 18.8 %, followed by Services: Business at 16 % and Beverage, Food & Tobacco at 8.1 %. First‑lien debt makes up close to 90 % of the portfolio, with subordinated debt accounting for 7.3 %. Total debt stood at about $1.09 billion, a 2 % decline from the end of 2025. Floating‑rate debt comprises 94.2 % of balance‑sheet leverage, while fixed‑rate debt represents 5.8 %, a mix that benefits the company when rates rise but could compress net interest margins if rates fall.

Credit Ratings and Performance

Fitch and Moody’s have assigned investment‑grade ratings of BBB and Baa3, respectively, to NCDL. Over the past year, the company delivered an average annual total return on net asset value of roughly 5.43 %, outperforming the peer group average of 2.8 %. Current market capitalization is near $621 million.

Market Positioning and Outlook

The disclosed metrics portray a stable market position anchored by disciplined credit risk management, ample liquidity, and a diversified portfolio. With investment‑grade ratings and a sizable floating‑rate balance sheet, NCDL appears positioned to navigate the prevailing interest‑rate environment while delivering returns that exceed its peers.

Source: seekingalpha.com · 2026-09-05

ipt>